BMY logo

Bristol-Myers Squibb Company (BMY) Cash From Financing

Annual CFF:

$5.13B+$14.54B(+154.45%)
December 31, 2024

Summary

  • As of today, BMY annual cash from financing is $5.13 billion, with the most recent change of +$14.54 billion (+154.45%) on December 31, 2024.
  • During the last 3 years, BMY annual cash from financing has risen by +$21.35 billion (+131.60%).
  • BMY annual cash from financing is now -32.73% below its all-time high of $7.62 billion, reached on December 31, 2019.

Performance

BMY Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

Quarterly CFF:

-$1.84B-$843.00M(-84.89%)
June 30, 2025

Summary

  • As of today, BMY quarterly cash from financing is -$1.84 billion, with the most recent change of -$843.00 million (-84.89%) on June 30, 2025.
  • Over the past year, BMY quarterly cash from financing has increased by +$2.19 billion (+54.36%).
  • BMY quarterly cash from financing is now -110.05% below its all-time high of $18.27 billion, reached on June 30, 2019.

Performance

BMY Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

TTM CFF:

-$8.32B+$2.19B(+20.81%)
June 30, 2025

Summary

  • As of today, BMY TTM cash from financing is -$8.32 billion, with the most recent change of +$2.19 billion (+20.81%) on June 30, 2025.
  • Over the past year, BMY TTM cash from financing has dropped by -$14.75 billion (-229.48%).
  • BMY TTM cash from financing is now -155.71% below its all-time high of $14.94 billion, reached on June 30, 2019.

Performance

BMY TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BMY Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+154.4%+54.4%-229.5%
3Y3 Years+131.6%+47.8%+44.2%
5Y5 Years-32.7%-84.9%+32.4%

BMY Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+130.2%-112.5%+64.4%-200.5%+52.9%
5Y5-Year-32.7%+130.2%-112.5%+74.8%-200.5%+52.9%
All-TimeAll-Time-32.7%+130.2%-110.0%+76.1%-155.7%+52.9%

BMY Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$1.84B(-84.9%)
-$8.32B(+20.8%)
Mar 2025
-
-$993.00M(+39.5%)
-$10.51B(-305.0%)
Dec 2024
$5.13B(+154.4%)
-$1.64B(+57.4%)
$5.13B(-33.7%)
Sep 2024
-
-$3.85B(+4.3%)
$7.74B(+20.3%)
Jun 2024
-
-$4.02B(-127.5%)
$6.43B(-22.3%)
Mar 2024
-
$14.64B(+1414.4%)
$8.28B(+187.9%)
Dec 2023
-$9.42B(+44.5%)
$967.00M(+118.7%)
-$9.42B(+30.9%)
Sep 2023
-
-$5.16B(-137.5%)
-$13.63B(-4.7%)
Jun 2023
-
-$2.17B(+28.8%)
-$13.01B(+9.4%)
Mar 2023
-
-$3.05B(+6.0%)
-$14.36B(+15.3%)
Dec 2022
-$16.96B(-4.5%)
-$3.25B(+28.5%)
-$16.96B(+4.1%)
Sep 2022
-
-$4.54B(-29.1%)
-$17.68B(-18.5%)
Jun 2022
-
-$3.52B(+37.7%)
-$14.92B(-2.3%)
Mar 2022
-
-$5.65B(-42.5%)
-$14.58B(+10.1%)
Dec 2021
-$16.22B(-1309.6%)
-$3.97B(-122.9%)
-$16.22B(-84.9%)
Sep 2021
-
-$1.78B(+44.1%)
-$8.77B(+8.4%)
Jun 2021
-
-$3.18B(+56.4%)
-$9.58B(-29.6%)
Mar 2021
-
-$7.29B(-309.4%)
-$7.39B(-542.2%)
Dec 2020
-$1.15B(-115.1%)
$3.48B(+234.6%)
-$1.15B(+90.7%)
Sep 2020
-
-$2.59B(-160.5%)
-$12.31B(-15.4%)
Jun 2020
-
-$993.00M(+5.8%)
-$10.66B(-224.1%)
Mar 2020
-
-$1.05B(+86.3%)
$8.60B(+12.8%)
Dec 2019
$7.62B(+315.6%)
-$7.68B(-715.8%)
$7.62B(-48.2%)
Sep 2019
-
-$941.00M(-105.2%)
$14.72B(-1.5%)
Jun 2019
-
$18.27B(+1000.3%)
$14.94B(+444.1%)
Mar 2019
-
-$2.03B(-251.0%)
-$4.34B(-22.8%)
Dec 2018
-$3.54B(+13.3%)
-$578.00M(+19.7%)
-$3.54B(+18.0%)
Sep 2018
-
-$720.00M(+29.1%)
-$4.31B(-0.3%)
Jun 2018
-
-$1.01B(+16.9%)
-$4.29B(-0.2%)
Mar 2018
-
-$1.22B(+9.6%)
-$4.29B(-5.1%)
Dec 2017
-$4.08B(-66.7%)
-$1.35B(-91.5%)
-$4.08B(-23.0%)
Sep 2017
-
-$706.00M(+29.8%)
-$3.31B(-5.3%)
Jun 2017
-
-$1.01B(+0.7%)
-$3.15B(-18.1%)
Mar 2017
-
-$1.01B(-71.7%)
-$2.67B(-9.0%)
Dec 2016
-$2.44B(+27.0%)
-$590.00M(-9.5%)
-$2.44B(+16.9%)
Sep 2016
-
-$539.00M(-2.9%)
-$2.94B(+5.2%)
Jun 2016
-
-$524.00M(+33.8%)
-$3.10B(+10.4%)
Mar 2016
-
-$792.00M(+27.1%)
-$3.46B(-3.3%)
Dec 2015
-$3.35B(-37.5%)
-$1.09B(-55.1%)
-$3.35B(-34.3%)
Sep 2015
-
-$700.00M(+20.7%)
-$2.50B(-7.4%)
Jun 2015
-
-$883.00M(-29.5%)
-$2.32B(-20.6%)
Mar 2015
-
-$682.00M(-195.2%)
-$1.93B(+20.9%)
Dec 2014
-$2.44B(-128.2%)
-$231.00M(+56.3%)
-$2.44B(-63.0%)
Sep 2014
-
-$528.00M(-8.6%)
-$1.50B(+5.8%)
Jun 2014
-
-$486.00M(+59.2%)
-$1.59B(+28.4%)
Mar 2014
-
-$1.19B(-267.7%)
-$2.22B(-107.5%)
Dec 2013
-$1.07B(+75.4%)
$711.00M(+214.7%)
-$1.07B(+61.0%)
Sep 2013
-
-$620.00M(+44.4%)
-$2.74B(+28.1%)
Jun 2013
-
-$1.11B(-2434.1%)
-$3.81B(-7.5%)
Mar 2013
-
-$44.00M(+95.4%)
-$3.54B(+18.3%)
Dec 2012
-$4.33B(-63.1%)
-$958.00M(+43.3%)
-$4.33B(-4.9%)
Sep 2012
-
-$1.69B(-98.7%)
-$4.13B(-31.3%)
Jun 2012
-
-$850.00M(-1.7%)
-$3.14B(-12.2%)
Mar 2012
-
-$836.00M(-10.9%)
-$2.80B(-5.4%)
Dec 2011
-$2.66B(+20.5%)
-$754.00M(-7.1%)
-$2.66B(+25.5%)
Sep 2011
-
-$704.00M(-38.9%)
-$3.57B(-0.2%)
Jun 2011
-
-$507.00M(+26.7%)
-$3.56B(-0.3%)
Mar 2011
-
-$692.00M(+58.4%)
-$3.55B(-6.2%)
Dec 2010
-$3.34B(>-9900.0%)
-$1.66B(-138.4%)
-$3.34B(-388.0%)
Sep 2010
-
-$698.00M(-41.0%)
-$685.00M(-6.5%)
Jun 2010
-
-$495.00M(-1.9%)
-$643.00M(+25.1%)
Mar 2010
-
-$486.00M(-148.9%)
-$858.00M(-4947.1%)
Dec 2009
-$17.00M(+99.3%)
$994.00M(+251.5%)
-$17.00M(+98.9%)
Sep 2009
-
-$656.00M(+7.6%)
-$1.61B(+49.4%)
Jun 2009
-
-$710.00M(-300.0%)
-$3.19B(-113.7%)
Mar 2009
-
$355.00M(+158.9%)
-$1.49B(+42.2%)
Dec 2008
-$2.58B(+19.6%)
-$603.00M(+73.0%)
-$2.58B(-3.2%)
Sep 2008
-
-$2.23B(-326.0%)
-$2.50B(-18.4%)
Jun 2008
-
$988.00M(+234.6%)
-$2.11B(+37.2%)
Mar 2008
-
-$734.00M(-40.1%)
-$3.37B(-4.8%)
Dec 2007
-$3.21B(+4.1%)
-$524.00M(+71.6%)
-$3.21B(+28.0%)
Sep 2007
-
-$1.84B(-598.5%)
-$4.46B(-38.5%)
Jun 2007
-
-$264.00M(+54.6%)
-$3.22B(+9.1%)
Mar 2007
-
-$581.00M(+67.3%)
-$3.55B(-5.8%)
Dec 2006
-$3.35B
-$1.77B(-193.9%)
-$3.35B(-1060.2%)
Sep 2006
-
-$604.00M(-2.9%)
$349.00M(-21.9%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$587.00M(-52.5%)
$447.00M(+122.8%)
Mar 2006
-
-$385.00M(-120.0%)
-$1.96B(+46.2%)
Dec 2005
-$3.64B(-685.5%)
$1.93B(+480.4%)
-$3.64B(+39.1%)
Sep 2005
-
-$506.00M(+83.1%)
-$5.97B(-11.6%)
Jun 2005
-
-$2.99B(-44.8%)
-$5.35B(-102.1%)
Mar 2005
-
-$2.06B(-408.6%)
-$2.65B(-471.5%)
Dec 2004
-$463.00M(+55.1%)
-$406.00M(-456.1%)
-$463.00M(+15.8%)
Sep 2004
-
$114.00M(+139.4%)
-$550.00M(+27.2%)
Jun 2004
-
-$289.00M(-344.9%)
-$756.00M(+44.3%)
Mar 2004
-
$118.00M(+123.9%)
-$1.36B(-31.7%)
Dec 2003
-$1.03B(+7.7%)
-$493.00M(-435.9%)
-$1.03B(-107.0%)
Sep 2003
-
-$92.00M(+89.7%)
-$498.00M(+50.6%)
Jun 2003
-
-$891.00M(-300.2%)
-$1.01B(-330.8%)
Mar 2003
-
$445.00M(+1012.5%)
-$234.00M(+79.1%)
Dec 2002
-$1.12B(-163.2%)
$40.00M(+106.6%)
-$1.12B(+68.0%)
Sep 2002
-
-$602.00M(-414.5%)
-$3.49B(-202.0%)
Jun 2002
-
-$117.00M(+73.3%)
$3.42B(+39.5%)
Mar 2002
-
-$438.00M(+81.3%)
$2.45B(+38.8%)
Dec 2001
$1.77B(+142.5%)
-$2.34B(-137.0%)
$1.77B(-42.2%)
Sep 2001
-
$6.32B(+681.0%)
$3.06B(+171.9%)
Jun 2001
-
-$1.09B(+3.3%)
-$4.25B(-1.3%)
Mar 2001
-
-$1.12B(-7.5%)
-$4.20B(-1.0%)
Dec 2000
-$4.16B(-30.0%)
-$1.05B(-4.8%)
-$4.16B(-0.9%)
Sep 2000
-
-$998.00M(+3.3%)
-$4.12B(-6.3%)
Jun 2000
-
-$1.03B(+4.5%)
-$3.88B(-11.6%)
Mar 2000
-
-$1.08B(-7.0%)
-$3.47B(-8.6%)
Dec 1999
-$3.20B(-7.3%)
-$1.01B(-34.3%)
-$3.20B(-17.4%)
Sep 1999
-
-$752.00M(-19.4%)
-$2.73B(-5.1%)
Jun 1999
-
-$630.00M(+21.8%)
-$2.59B(+12.8%)
Mar 1999
-
-$806.00M(-50.1%)
-$2.97B(+0.2%)
Dec 1998
-$2.98B(-38.5%)
-$537.00M(+13.4%)
-$2.98B(+3.7%)
Sep 1998
-
-$620.00M(+38.7%)
-$3.10B(-6.3%)
Jun 1998
-
-$1.01B(-24.5%)
-$2.91B(-14.5%)
Mar 1998
-
-$812.00M(-24.3%)
-$2.54B(-18.3%)
Dec 1997
-$2.15B(-14.1%)
-$653.00M(-49.4%)
-$2.15B(-21.2%)
Sep 1997
-
-$437.00M(+31.9%)
-$1.77B(-2.7%)
Jun 1997
-
-$642.00M(-53.2%)
-$1.73B(-4.0%)
Mar 1997
-
-$419.00M(-51.3%)
-$1.66B(+11.8%)
Dec 1996
-$1.89B(-1.4%)
-$277.00M(+29.2%)
-$1.89B(+9.9%)
Sep 1996
-
-$391.00M(+32.0%)
-$2.09B(+11.4%)
Jun 1996
-
-$575.00M(+10.4%)
-$2.36B(-10.4%)
Mar 1996
-
-$642.00M(-32.9%)
-$2.14B(-15.0%)
Dec 1995
-$1.86B(-13.4%)
-$483.00M(+26.9%)
-$1.86B(+6.3%)
Sep 1995
-
-$661.00M(-87.8%)
-$1.99B(-53.8%)
Jun 1995
-
-$352.00M(+3.0%)
-$1.29B(+16.2%)
Mar 1995
-
-$363.00M(+40.4%)
-$1.54B(+6.0%)
Dec 1994
-$1.64B(+3.6%)
-$609.00M(-1945.5%)
-$1.64B(-5.3%)
Sep 1994
-
$33.00M(+105.5%)
-$1.56B(+28.1%)
Jun 1994
-
-$602.00M(-30.6%)
-$2.17B(-28.2%)
Mar 1994
-
-$461.00M(+12.5%)
-$1.69B(+0.6%)
Dec 1993
-$1.70B(+2.7%)
-$527.00M(+8.5%)
-$1.70B(-10.1%)
Sep 1993
-
-$576.00M(-360.8%)
-$1.54B(-16.8%)
Jun 1993
-
-$125.00M(+73.5%)
-$1.32B(+20.9%)
Mar 1993
-
-$472.00M(-27.2%)
-$1.67B(+4.4%)
Dec 1992
-$1.75B(-10.8%)
-$371.00M(-4.8%)
-$1.75B(+2.1%)
Sep 1992
-
-$354.00M(+25.3%)
-$1.78B(-1.5%)
Jun 1992
-
-$474.00M(+13.7%)
-$1.76B(-9.9%)
Mar 1992
-
-$549.00M(-34.6%)
-$1.60B(-1.5%)
Dec 1991
-$1.58B(-5.6%)
-$408.00M(-24.8%)
-$1.58B(-1.9%)
Sep 1991
-
-$327.00M(-3.5%)
-$1.55B(+8.6%)
Jun 1991
-
-$316.00M(+39.9%)
-$1.69B(+0.9%)
Mar 1991
-
-$526.00M(-38.8%)
-$1.71B(-14.5%)
Dec 1990
-$1.49B(-48.2%)
-$379.00M(+19.9%)
-$1.49B(-34.0%)
Sep 1990
-
-$473.00M(-42.5%)
-$1.11B(-73.7%)
Jun 1990
-
-$332.00M(-7.1%)
-$642.00M(-107.1%)
Mar 1990
-
-$310.00M
-$310.00M
Dec 1989
-$1.01B(-77.9%)
-
-
Dec 1988
-$566.50M(-58.6%)
-
-
Dec 1987
-$357.10M(-43.8%)
-
-
Dec 1986
-$248.30M(-43.8%)
-
-
Dec 1985
-$172.70M(-4.5%)
-
-
Dec 1984
-$165.20M(+0.4%)
-
-
Dec 1983
-$165.90M(-76.1%)
-
-
Dec 1982
-$94.20M(+18.9%)
-
-
Dec 1981
-$116.20M(-20.8%)
-
-
Dec 1980
-$96.20M
-
-

FAQ

  • What is Bristol-Myers Squibb Company annual cash from financing?
  • What is the all-time high annual cash from financing for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company annual cash from financing year-on-year change?
  • What is Bristol-Myers Squibb Company quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company quarterly cash from financing year-on-year change?
  • What is Bristol-Myers Squibb Company TTM cash from financing?
  • What is the all-time high TTM cash from financing for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company TTM cash from financing year-on-year change?

What is Bristol-Myers Squibb Company annual cash from financing?

The current annual cash from financing of BMY is $5.13B

What is the all-time high annual cash from financing for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high annual cash from financing is $7.62B

What is Bristol-Myers Squibb Company annual cash from financing year-on-year change?

Over the past year, BMY annual cash from financing has changed by +$14.54B (+154.45%)

What is Bristol-Myers Squibb Company quarterly cash from financing?

The current quarterly cash from financing of BMY is -$1.84B

What is the all-time high quarterly cash from financing for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high quarterly cash from financing is $18.27B

What is Bristol-Myers Squibb Company quarterly cash from financing year-on-year change?

Over the past year, BMY quarterly cash from financing has changed by +$2.19B (+54.36%)

What is Bristol-Myers Squibb Company TTM cash from financing?

The current TTM cash from financing of BMY is -$8.32B

What is the all-time high TTM cash from financing for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high TTM cash from financing is $14.94B

What is Bristol-Myers Squibb Company TTM cash from financing year-on-year change?

Over the past year, BMY TTM cash from financing has changed by -$14.75B (-229.48%)
On this page